ETFS

Get ready for the digital dollar and what it will mean for you. ?30 Minute Chart Club- Join Free! ? https://thecontrariantrader.lpages.co/30-minute-chart-club/ ✅Bob’s 5 Most Powerful Candlestick Patterns Video Tutorial – Free candlestick opt-in series 2 ✅14 Day Free Trial Final Days! Hurry! Join 2 Weeks Free ================================================= Our Preferred Sponsors Charting; ?TrendSpider Automated Charting Tour
0 Comments
In this livestream we review our top stocks on a 30 minute timeframe and decide which stocks look best from a technical analysis perspective using TrendSpider which is AI charting software. This weeks top stocks which we did technical analysis on were ABNB, GOOGL, ZM and COIN. ?30 Minute Chart Club- Join Free! ? https://thecontrariantrader.lpages.co/30-minute-chart-club/
0 Comments
Warning: Undefined array key 0 in /home/etfdailynews/public_html/wp-content/themes/responsalambre/functions.php on line 144 wp-content/themes/responsalambre/images/image-pending.gif&w=240&h=240&zc=2″ class=”ff-og-image-inserted”> Vanguard High Dividend Yield ETF (VYM) could be the ideal vehicle to anchor investors’ portfolios to stable income-generating assets while market returns from capital appreciation remain anything but predictable and guaranteed. The recently released estimate-crushing inflation data caused the market to relapse into yet another
0 Comments
Dream Industrial Real Estate Invest Trst (TSE:DIR.UN – Get Rating) has been assigned a C$17.00 target price by research analysts at BMO Capital Markets in a report issued on Wednesday, BayStreet.CA reports. The firm currently has an “outperform” rating on the stock. BMO Capital Markets’ price objective would suggest a potential upside of 15.18% from
0 Comments
Tonight, we will discuss if we are in a new bull market or if this is a bull trap. We will also review TSLA stock. ?30 Minute Chart Club- Join Free! ? https://thecontrariantrader.lpages.co/30-minute-chart-club/ ✅Bob’s 5 Most Powerful Candlestick Patterns Video Tutorial – Free candlestick opt-in series 2 ✅14 Day Free Trial Final Days! Hurry! Join
0 Comments
HomeTrust Bancshares (NASDAQ:HTBI – Get Rating) was upgraded by investment analysts at Piper Sandler from a “neutral” rating to an “overweight” rating in a research note issued to investors on Tuesday, Marketbeat Ratings reports. The firm currently has a $32.00 target price on the financial services provider’s stock, up from their previous target price of
0 Comments
Warning: Undefined array key 0 in /home/etfdailynews/public_html/wp-content/themes/responsalambre/functions.php on line 144 wp-content/themes/responsalambre/images/image-pending.gif&w=240&h=240&zc=2″ class=”ff-og-image-inserted”> High inflation, rising interest rates, and geopolitical uncertainty crippled the major market indexes last year. The indexes have enjoyed a respite from the turbulence earlier this year. However, since the market has turned volatile again on concerns over the Fed’s potential interest rate
0 Comments
Doximity (NASDAQ:DOCS – Get Rating) and Computer Programs and Systems (NASDAQ:CPSI – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings. Institutional & Insider Ownership 52.5% of Doximity shares are
0 Comments
MetLife Investment Management LLC decreased its position in shares of Highwoods Properties, Inc. (NYSE:HIW – Get Rating) by 1.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,524 shares of the real estate investment trust’s stock after selling 831 shares during the
0 Comments
Edgewell Personal Care Co (NYSE:EPC – Get Rating) has received an average recommendation of “Hold” from the nine brokerages that are presently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and three have given a buy recommendation to the company. The
0 Comments
Hsbc Holdings PLC boosted its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Rating) by 63.2% during the 3rd quarter, HoldingsChannel reports. The firm owned 82,904 shares of the biopharmaceutical company’s stock after buying an additional 32,118 shares during the quarter. Hsbc Holdings PLC’s holdings in Halozyme Therapeutics were worth $3,279,000 as of its most
0 Comments